Patients with treatment-resistant depression may find relief through either TMS therapy or Spravato (esketamine) treatment. TMS therapy in Hackensack, NJ, is a non-medication option that utilizes magnetic stimulation to enhance mood. On the other hand, Spravato is a rapid-acting treatment specifically designed for patients who haven't had success with traditional antidepressants. Our team will work with you to identify the most suitable treatment for your needs.
Spravato (esketamine) is an FDA-approved nasal spray specifically designed for adults suffering from treatment-resistant depression, particularly when conventional antidepressants have proven ineffective. Unlike traditional medications, esketamine acts on different brain pathways, offering rapid relief from depressive symptoms, often within just days to weeks. This treatment is administered in a certified medical environment under professional supervision to ensure both safety and effectiveness. At iChange Wellness Center, we provide Spravato treatment in West New York, NJ, as part of our comprehensive and personalized approach to managing depression.

Esketamine, marketed under the brand name SPRAVATO®, has two FDA-approved indications. According to the package insert for SPRAVATO®, esketamine is indicated, along with an oral antidepressant, for the treatment of treatment-resistant depression (TRD) in adults and for managing depressive symptoms in adults with major depressive disorder (MDD) experiencing acute suicidal ideation (SI) or behavior.
The treatment recommended for treatment-resistant depression with esketamine, commercially known as Spravato, involves sessions twice per week for four weeks, followed by weekly treatments for an additional four weeks. During these treatment sessions, patients are monitored and supervised in the facility for 2 hours and must arrange for a documented safe ride home. It is important to note that patients cannot drive until they have had a full night's rest.
1. No liquids 30 minutes before the administration of esketamine (Spravato).
2. No food for 2 hours prior to the administration of Spravato to ensure optimal results in treating treatment-resistant depression.
3. Avoid the use of any nasal decongestant spray or steroid.
4. Patients should refrain from operating machinery or vehicles until they have had a good night's rest; it may be advisable for them to have someone accompany them upon discharge.
If you have any questions or concerns about our esketamine treatment options, including Spravato for treatment-resistant depression, don't hesitate to contact us. Our friendly staff are always here to help. You can reach us via phone, email, or by filling out our online contact form.
Please reach us at info@njpremierpsych.com if you cannot find an answer to your question.
Spravato® (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression (TRD) or depression with suicidal thoughts.
Unlike traditional antidepressants, Spravato works on the glutamate system, helping the brain form new connections and improve mood more rapidly.
Most antidepressants affect serotonin or norepinephrine and may take weeks to work.
Spravato:
Treatment is done in-office under medical supervision:
You may experience:

TMS therapy in Hackensack offers a non-medication approach to treating depression, including options for those struggling with treatment-resistant depression. For patients seeking alternative solutions, esketamine, marketed as Spravato, presents another innovative option.
Hours by appointment only for esketamine and Spravato treatments for treatment-resistant depression.
Open today | 09:00 am – 05:00 pm |